The largest Scandinavian insect factory, Enorm Biofactory, struggles with the deficiency of request and protests of residents. Does the insect protein manufacture have a chance to develop?
Enorm Biofactory in Trouble: Restructuring and protests
Danish insect protein producer, Enorm Biofactoryinitiating the restructuring procedure. Company, specializing in black fly larvae (Hermetia illuscens) is incapable to find adequate recipients of its product. At the same time, residents of the surrounding areas are complaining of a nuisance, resulting in intervention by the Danish Environmental Protection Agency.
Carsten Lind Pedersen, CEO of Enorm Biofactory, admits that lack of marketplace interest hinders the maintenance of liquidity. Nevertheless, the company does not resign and seeks fresh partners or changes in the business structure.
The largest insect mill in Scandinavia
Enorm Biofactory claims she built the largest plant producing insect protein in Scandinavia. Factory, located in Central Jutland, has production capacity 100 tonnes of larvae per daywhich translates into 11,000 tonnes of protein per year.
Company cooperates with DLG Group, 1 of the largest European agri-food companies. Produced by her insect flour and oil to be an alternate to soya protein in animal feed.
Environmental problems and protests of residents
Despite ambitious plans, the mill has been struggling for months protests by the local community. Residents complain about unpleasant smellsWhich led the authorities to control. There was even information about temporary cessation of production.
Does insect protein have a future?
The insect protein manufacture is seen as an ecological alternate to conventional feed. According to the study FAO (United Nations Food and Agriculture Organisation), insect breeding consumes much little water and land than conventional protein production.
However, consumer opposition and logistical problems they are inactive hampering marketplace development. W European Union the release of insects for human and animal consumption requires strict regulation. In 2023. EFSA (European Food Safety Authority) issued affirmative reviews for respective insect species, but inactive missing a single promotion strategy.
Summary: challenges and opportunities
Enorm Biofactory is an example of a company that put it on a niche but forward-looking market. However, Lack of demand, environmental and regulatory problems they show that the manufacture inactive needs time to develop.
Will insect protein become A nutritional revolutionor just Short-term trend? Time will tell.
Read more:
Danish insect mill in crisis. Plan von der Leyen feeding Europeans bugs failed